Pluri Inc. (PLUR) vs Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX)

Pluri Inc. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are both Biotechnology companies. Pluri Inc. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are of similar size ($13.0M and $12.8M). Quoin Pharmaceuticals, Ltd. Sponsored ADR has the higher net margin (0.00% vs −2,344.6%) and the higher return on invested capital (0.00% vs −526.9%). Across the 13 metrics below, Quoin Pharmaceuticals, Ltd. Sponsored ADR leads on 7 and Pluri Inc. on 6.

Valuation

Metric PLUR QNRX Biotechnology median
P/E n/m n/m 7.88
P/S 10.07 n/m 11.47
P/B n/m 4.63 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 30.14 n/m 10.73
Earnings yield (233.33%) (391.60%) (28.84%)
Free cash flow yield (197.46%) (15.72%) (23.03%)

Profitability

Metric PLUR QNRX Biotechnology median
Gross margin 44.59% 0.00% 65.16%
Operating margin (2,454.53%) 0.00% 0.00%
Net margin (2,344.59%) 0.00% 0.00%
Free cash flow margin (1,988.48%) 0.00% 0.00%
Return on equity 260.35% (575.73%) (57.72%)
Return on assets (74.95%) (178.77%) (49.22%)
Return on invested capital (526.92%) 0.00% 0.00%

Growth

Metric PLUR QNRX Biotechnology median
Revenue growth (TTM) (23.95%) — 5.64%
EPS growth (last fiscal year) 31.46% 77.84% —
Revenue growth, 5-year CAGR 113.32% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PLUR QNRX Biotechnology median
Debt to equity (1.62) 0.00 0.00
Current ratio 0.27 1.76 4.73
Net debt to EBITDA (0.83) 1.16 0.96

Dividend

Metric PLUR QNRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PLUR QNRX Biotechnology median
Market cap 12.96m 12.82m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack